David Langlais Selected Research

Leishmania glycoprotein gp63 (leishmanolysin)

1/2021

The role of Leishmania GP63 in the modulation of innate inflammatory response to Leishmania major infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Langlais Research Topics

Disease

8	Infections 01/2021 - 10/2008
5	Inflammation (Inflammations) 10/2021 - 01/2017
5	Neuroinflammatory Diseases 01/2020 - 01/2013
4	Neoplasms (Cancer) 10/2021 - 01/2016
3	Cerebral Malaria 01/2020 - 01/2017
2	Tuberculosis (Tuberculoses) 01/2021 - 06/2011
1	COVID-19 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 10/2021
1	Bone Marrow Failure Disorders 10/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Carcinogenesis 01/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2020
1	Colitis-Associated Neoplasms 12/2019
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Genomic Instability 01/2019
1	Liposarcoma 08/2017
1	Sarcoma (Soft Tissue Sarcoma) 08/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017
1	Adenoma (Adenomas) 02/2016
1	Pituitary ACTH Hypersecretion 02/2016
1	Virus Diseases (Viral Diseases) 12/2014
1	Chromosomal Instability (Chromosome Stability) 07/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
4	CytokinesIBA 01/2020 - 10/2008
3	RNA (Ribonucleic Acid)IBA 12/2019 - 01/2013
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2021
2	ChromatinIBA 01/2021 - 01/2013
2	AzoxymethaneIBA 12/2019 - 01/2016
2	Dextran SulfateIBA 12/2019 - 01/2016
2	Interferon Type IIBA 01/2017 - 11/2016
2	GlucocorticoidsIBA 02/2016 - 10/2008
1	nintedanibIBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	InterferonsIBA 10/2021
1	Leishmania glycoprotein gp63 (leishmanolysin)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2020
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 12/2019
1	Ubiquitin-Specific ProteasesIBA 01/2019
1	Deubiquitinating EnzymesIBA 01/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2019
1	Proto-Oncogene Proteins c-etsIBA 08/2017
1	Interferon Regulatory FactorsIBA 08/2017
1	EnzymesIBA 01/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2016
1	Natural Killer Cell ReceptorsIBA 12/2014
1	Cre recombinaseIBA 07/2013
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 06/2011
1	Interleukin-12 (IL 12)IBA 06/2011
1	Interferon-gamma (Interferon, gamma)IBA 06/2011

Therapy/Procedure

1	Radiotherapy 10/2021